左心室辅助装置在心力衰竭的管理:一个单一中心的经验
Sam Karem1, Rajasekhar S R Malyala2, Sibu Saha3
1MS3 at University of Kentucky College of Medicine, Lexington, Kentucky.
概括
左心室辅助器械 (LVAD) 治疗有助于管理晚期心力衰竭. 这项研究审查了肯塔基大学的LVAD结果,发现许多患者的生活质量有所改善,尽管出现了并发症.
科学领域:
- 心脏病学 心脏病学
- 医疗器械 医疗器械
- 心脏衰竭管理的管理
背景情况:
- 心力衰竭在美国是一个重大的医疗保健挑战.
- 左心室辅助器件 (LVAD) 为医疗上难以治疗的心力衰竭病例提供了解决方案.
研究的目的:
- 评估左心室辅助器件 (LVAD) 治疗的结果.
- 在肯塔基大学评估LVAD植入后患者的生活质量.
主要方法:
- 对于LVAD植入的患者记录的回顾性审查.
- 从2017年1月1日至2021年12月31日期间收集的数据.
- 分析包括患者人口统计,住院时间,生活质量 (NYHA分类),生存率和术后并发症.
主要成果:
- 127名符合条件的患者 (18-83岁) 接受了LVADs.
- 在纽约心脏协会 (NYHA) 的功能分类中观察到显著的改善.
- 报告的术后并发症包括中风 (26%),胃肠道出血 (24.4%),功能衰竭 (26%),呼吸功能衰竭 (44.8%),驱动线感染 (37%) 和右心室功能障碍 (14.2%).
结论:
- 左心室辅助装置 (LVAD) 植入是治疗晚期心力衰竭的可行策略.
- LVAD治疗可以改善患者的生活质量.
- 仔细监测和管理术后并发症对于成功的LVAD结果至关重要.
相关概念视频
Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
Cardiomyopathy V: Interprofessional Care
34
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
34
Heart Failure VI: Adjunct Therapies
28
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
28
Cardiomyopathy II: Dilated Cardiomyopathy
22
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
22


